Entering text into the input field will update the search result below

Absci teams up to help develop antibody drugs for cancer

Jul. 07, 2022 8:12 AM ETAbsci Corporation (ABSI)By: Ravikash, SA News Editor

Business agreement


  • Absci (NASDAQ:ABSI) said it signed a collaboration agreement with an undisclosed biotech company.
  • Absci noted that the partner is a stealth-mode company, led by biotech industry executives, focused on developing antibody-drug-conjugates (ADCs) initially for cancer indications.
  • The partner

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.